Gennao Bio, Juno Diagnostics Raise Series A FundingBiopharma, Business, Financing, Nucleic acid therapeutics, Prenatal Testing, Series A, Skeletal MuscleBiopharma companies Gennao Bio and Juno Diagnostics raised a combined $65 million in Series A funding rounds. Read more May 12, 2021/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2021/05/Gennao-Bio-Juno-Diagnostics-Break-Onto-the-Scene-With-Combined-65-Million-BioSpace-5-12-21.jpeg 350 625 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2021-05-12 11:22:242021-05-12 14:58:29Gennao Bio, Juno Diagnostics Raise Series A Funding